Douglas Clark Wurth, Director at Bluejay Diagnostics, Inc. (BJDX), bought 12,500 shares at $2.00 ($25K) on 2026-03-14, disclosed to the SEC on 2026-05-18.
Open-market purchase of $25k BJDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |